Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Fiorenzo, Santoleri"'
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study
Autor:
Fiorenzo Santoleri, Paolo Abrate, Laura Pestrin, Enrico Pasut, Germana Modesti, Felice Musicco, Chiara Fulgenzio, Eva Zuzolo, Gabriella Pieri, Martina Roperti, Pietro Gazzola, Marco Gambera, Isabella Martignoni, Valentina Montresor, Francesca Guarino, Laura Grossi, Letizia Di Fabio, Cristina Roberti, Concetta Spoltore, Gabriella Tinari, Stefania De Rosa, Romina Giannini, Roberto Langella, Grazia Mingolla, Mariantonietta Piccoli, Alberto Costantini
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss 1 (2024)
Introduction: This study aims to evaluate the persistence, treatment adherence and drug cost associated with biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in the management of psoriatic arthritis (PsA) in Italy, w
Externí odkaz:
https://doaj.org/article/a5f5d14afc0945e59c39275f3305599a
Autor:
Michele Ciulla, Lisa Marinelli, Giuseppe Di Biase, Ivana Cacciatore, Fiorenzo Santoleri, Alberto Costantini, Marilisa Pia Dimmito, Antonio Di Stefano
Publikováno v:
Healthcare, Vol 11, Iss 3, p 447 (2023)
This systematic study aims at analyzing the differences between the approach of the European healthcare systems to the pharmaceutical market and the American one. This paper highlights the opportunities and the limitations given by the application of
Externí odkaz:
https://doaj.org/article/98dc099d323d4d9eb11695a7c1057665
Autor:
Ruggero Lasala, Andrea Zovi, Valentina Isgrò, Alessia Romagnoli, Felice Musicco, Fiorenzo Santoleri
Publikováno v:
Current Medical Research and Opinion. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0e51dceaef34c473b717a50feccea7
https://doi.org/10.1080/03007995.2023.2192610
https://doi.org/10.1080/03007995.2023.2192610
Autor:
Valentina Perrone, Melania Dovizio, Diego Sangiorgi, Margherita Andretta, Fausto Bartolini, Arturo Cavaliere, Andrea Ciaccia, Alessandro Chinellato, Alberto Costantini, Stefania Dell’Orco, Fulvio Ferrante, Simona Gentile, Antonella Lavalle, Rossella Moscogiuri, Elena Mosele, Cataldo Procacci, Davide Re, Fiorenzo Santoleri, Alessandro Roccia, Franco Maggiolo, Luca Degli Esposti
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 20
Issue 5
Pages: 3789
Volume 20
Issue 5
Pages: 3789
This real-world analysis conducted on administrative databases of a sample of Italian healthcare entities was aimed at describing the role of therapeutic pathways and drug utilization in terms of adherence, persistence, and therapy discontinuation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563651a74fbd3dda8533b78cb1ff549f
Publikováno v:
European journal of hospital pharmacy : science and practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb93f254099b595c4cfb03f765ac912b
https://pubmed.ncbi.nlm.nih.gov/36283729
https://pubmed.ncbi.nlm.nih.gov/36283729
Autor:
Felice Musicco, Ruggero Lasala, Fiorenzo Santoleri, Alberto Costantini, Paolo Abrate, Maria Teresa Carretta, Enrica Maria Proli, Alessia Romagnoli, Nicola Petragnani, Francesco De Vita, Massimo Zeuli, Patrizia Vici, Massimo Sansone, Matilde Pasquantonio, Antonia La Malfa, Chiara Fulgenzio
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Objective Palbociclib, a highly selective reversible CDK4-6 kinase inhibitor, is indicated in combination with an aromatase inhibitor or in combination with fulvestrant in women who had received prior endocrine treatment. Studies have demonstrated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45a3aa7a60b8535c65f410cd565ec4a
https://pubmed.ncbi.nlm.nih.gov/35903919
https://pubmed.ncbi.nlm.nih.gov/35903919
Publikováno v:
Therapeutic innovationregulatory science.
To date, numerous biosimilars are available in Europe and the practice of switching between originator and biosimilar or between two different biosimilars has become very widespread. However, multiple switching has not been adequately studied. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cc62fcfa78679bff7d6e50c4be1092
https://pubmed.ncbi.nlm.nih.gov/36322326
https://pubmed.ncbi.nlm.nih.gov/36322326
Publikováno v:
Current Reviews in Clinical and Experimental Pharmacology. 16:109-116
Background: Persistence and adherence to treatment are considered efficacy outcomes in psychiatric disorders. One of the best ways to improve these values in patients with psychiatric disorders is to prefer Long-Acting Injectable (LAI) drugs to oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e18c23d89b4ebccf4d5c4e12cd33b69
https://doi.org/10.2174/1574884715666200309121932
https://doi.org/10.2174/1574884715666200309121932
Autor:
Fiorenzo Santoleri, Stefano Marinari, Caterina Di Fabio, Giovanni Petragnani, Francesco De Vita, Fabio Esposito, Luigia Auriemma, Alberto Costantini, Antonella Spacone, Letizia Di Fabio
Publikováno v:
Journal of Pharmacy Practice. 35:853-858
Background: In the treatment of idiopathic pulmonary fibrosis (IPF), nintedanib and pirfenidone, with their different mechanisms of action, lead to a reduction in the rate of progression of the fibrosis process measured by the reduction of functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be11cfc10ec48f121022150bd96f644
https://doi.org/10.1177/08971900211008625
https://doi.org/10.1177/08971900211008625
Autor:
Maria Monteverde, Caterina de Rosa, Felice Musicco, Francesca Federici, Giancarlo Torquati, Arianna Pasquazi, Anna Rita Scortechini, Alberto Costantini, Maria Cantonetti, Luca Franceschini, Antonietta Vozza, Angela Frazzetto, M Scaldaferri, Fabrizio Pane, Katiuscia Di Biagio, Chiara Rossi, Maria Grazia Celeste, Gaetano La Barba, Luigia Luciano, Irene Colasanto, Manuela Rizzo, Rosaria Lanzillo, Fiorenzo Santoleri, Francesco Cattel, Elena Ranucci
Publikováno v:
Current Medical Research and Opinion. 37:477-481
The use of dasatinib and nilotinib in the treatment of patients with chronic myeloid leukemia represents a valid therapeutic option for patients resistant or intolerant to imatinib. In this multicentre study, adherence, persistence and efficacy in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36bfb7ab914a3378219d9746e1715e8f
https://doi.org/10.1080/03007995.2021.1876006
https://doi.org/10.1080/03007995.2021.1876006